Chemotherapy paclitaxel. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Tumor Cells, Cultured Microtubules

Organisms2

Mice, Nude Taxus

Diseases68

Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Neutropenia Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Nausea Leukopenia Peritoneal Neoplasms Vomiting Carcinoma Testicular Neoplasms Thrombocytopenia Lymphoma, Non-Hodgkin Disease Progression Stomach Neoplasms Carcinoma, Squamous Cell Peripheral Nervous System Diseases Neoplasm Metastasis Neoplasms, Germ Cell and Embryonal Hematologic Diseases Neoplasms, Glandular and Epithelial Bone Neoplasms Brain Neoplasms Fallopian Tube Neoplasms Hodgkin Disease Head and Neck Neoplasms Colorectal Neoplasms Lymphatic Metastasis Recurrence Germinoma Liver Neoplasms Osteosarcoma Alopecia Stomatitis Lymphoma Carcinoma, Transitional Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma Sarcoma Neoplasm, Residual Urinary Bladder Neoplasms Cystadenocarcinoma, Serous Leukemia, Myeloid, Acute Colonic Neoplasms Vomiting, Anticipatory Genital Neoplasms, Female Esophageal Neoplasms Fatigue Urologic Neoplasms Agranulocytosis Mediastinal Neoplasms Pancreatic Neoplasms Anemia Nasopharyngeal Neoplasms Lymphoma, Large B-Cell, Diffuse Retroperitoneal Neoplasms Soft Tissue Neoplasms Neoplasms, Unknown Primary Mesothelioma Seminoma Drug Hypersensitivity Prostatic Neoplasms Neoplasms, Second Primary Central Nervous System Neoplasms Multiple Myeloma Drug-Related Side Effects and Adverse Reactions

Chemicals and Drugs79

Paclitaxel Antineoplastic Agents, Phytogenic Cisplatin Antineoplastic Agents Carboplatin Doxorubicin Cyclophosphamide Taxoids Etoposide Vinblastine Deoxycytidine Ifosfamide Bridged Compounds Methotrexate Tubulin Modulators Organoplatinum Compounds Anthracyclines Antimetabolites, Antineoplastic Granulocyte Colony-Stimulating Factor Antibodies, Monoclonal, Humanized Platinum Compounds P-Glycoprotein Antibiotics, Antineoplastic Antineoplastic Agents, Alkylating Bleomycin Epothilones Topotecan Cytarabine Tubulin Camptothecin Tegafur Antibodies, Monoclonal Pharmaceutical Vehicles Platinum Tumor Markers, Biological Receptor, erbB-2 Mitoxantrone Dacarbazine Carmustine Thiotepa Drug Carriers Melphalan Oxonic Acid Lomustine Antiemetics Epirubicin Mitomycin Angiogenesis Inhibitors Daunorubicin Quinazolines Biomarkers, Pharmacological Radiation-Sensitizing Agents Estramustine Mesna Vindesine Polyethylene Glycols Amifostine Drug Combinations Proto-Oncogene Proteins c-bcl-2 Albumins Receptors, Estrogen Floxuridine Dexamethasone Tamoxifen Antibodies, Monoclonal, Murine-Derived Micelles Fluorouracil Recombinant Proteins Polyglutamic Acid Prednisolone Cyclosporins Neoplasm Proteins Nimustine Antineoplastic Agents, Hormonal Tumor Suppressor Protein p53 Multidrug Resistance-Associated Proteins Granisetron Receptors, Progesterone Diphenhydramine

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Drug Administration Schedule Disease-Free Survival Survival Analysis Neoplasm Staging Survival Rate Neoadjuvant Therapy Infusions, Intravenous Prognosis Induction Chemotherapy Salvage Therapy Follow-Up Studies Maximum Tolerated Dose Kaplan-Meier Estimate Radiotherapy, Adjuvant Chemotherapy, Cancer, Regional Perfusion Xenograft Model Antitumor Assays Prospective Studies Area Under Curve Drug Screening Assays, Antitumor Transplantation, Autologous Feasibility Studies Radiotherapy Pharmaceutical Vehicles Clinical Trials as Topic Drug Delivery Systems Radiotherapy Dosage Drug Carriers Administration, Oral Infusions, Intra-Arterial Randomized Controlled Trials as Topic Hematopoietic Stem Cell Transplantation Clinical Trials, Phase III as Topic Chemoradiotherapy Palliative Care Drug Therapy Infusions, Parenteral Proportional Hazards Models Immunohistochemistry Multivariate Analysis Neoplasm Transplantation Pilot Projects Hyperthermia, Induced Maintenance Chemotherapy Actuarial Analysis Inhibitory Concentration 50 Clinical Trials, Phase II as Topic Tumor Burden Treatment Failure Dose Fractionation Predictive Value of Tests Cranial Irradiation Fatal Outcome Mastectomy Antineoplastic Protocols Bone Marrow Transplantation Hematopoietic Stem Cell Mobilization Drug Evaluation Tomography, X-Ray Computed Risk Factors Transplantation, Heterologous Flow Cytometry Radioimmunotherapy Cohort Studies Injections, Intravenous Consolidation Chemotherapy

Phenomena and Processes14

Drug Resistance, Neoplasm Dose-Response Relationship, Drug Time Factors Drug Synergism Maximum Tolerated Dose Apoptosis Drug Resistance, Multiple Area Under Curve Cell Survival Gene Expression Regulation, Neoplastic Cell Proliferation Inhibitory Concentration 50 Drug Interactions Cell Cycle

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Chemistry, Pharmaceutical

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Technology, Industry, Agriculture2

Nanoparticles Polyethylene Glycols

Humanities1

Quality of Life

Information Science2

Survival Rate Fatal Outcome

Health Care24

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Kaplan-Meier Estimate Prospective Studies Area Under Curve Feasibility Studies Clinical Trials as Topic Randomized Controlled Trials as Topic Clinical Trials, Phase III as Topic Palliative Care Proportional Hazards Models Multivariate Analysis Pilot Projects Actuarial Analysis Clinical Trials, Phase II as Topic Treatment Failure Predictive Value of Tests Fatal Outcome Antineoplastic Protocols Risk Factors Cohort Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care

Paclitaxel Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents, Phytogenic Chemotherapy, Adjuvant Cisplatin Antineoplastic Agents Carboplatin Doxorubicin Combined Modality Therapy Treatment Outcome Drug Administration Schedule Cyclophosphamide Breast Neoplasms Lung Neoplasms Disease-Free Survival Ovarian Neoplasms Drug Resistance, Neoplasm Taxoids Survival Analysis Neoplasm Staging Survival Rate Etoposide Vinblastine Neoadjuvant Therapy Carcinoma, Non-Small-Cell Lung Deoxycytidine Infusions, Intravenous Neutropenia Prognosis Neoplasms Ifosfamide Dose-Response Relationship, Drug Bridged Compounds Neoplasm Recurrence, Local Methotrexate Cell Line, Tumor Tubulin Modulators Induction Chemotherapy Organoplatinum Compounds Anthracyclines Salvage Therapy Antimetabolites, Antineoplastic Adenocarcinoma Time Factors Granulocyte Colony-Stimulating Factor Nausea Leukopenia Antibodies, Monoclonal, Humanized Platinum Compounds Peritoneal Neoplasms P-Glycoprotein Drug Synergism Follow-Up Studies Antibiotics, Antineoplastic Antineoplastic Agents, Alkylating Bleomycin Vomiting Maximum Tolerated Dose Apoptosis Carcinoma Mice, Nude Testicular Neoplasms Kaplan-Meier Estimate Radiotherapy, Adjuvant Epothilones Thrombocytopenia Topotecan Drug Resistance, Multiple Chemotherapy, Cancer, Regional Perfusion Cytarabine Tubulin Xenograft Model Antitumor Assays Lymphoma, Non-Hodgkin Tumor Cells, Cultured Disease Progression Stomach Neoplasms Prospective Studies Area Under Curve Carcinoma, Squamous Cell Taxus Drug Screening Assays, Antitumor Camptothecin Transplantation, Autologous Peripheral Nervous System Diseases Neoplasm Metastasis Feasibility Studies Radiotherapy Neoplasms, Germ Cell and Embryonal Tegafur Hematologic Diseases Antibodies, Monoclonal Pharmaceutical Vehicles Clinical Trials as Topic Neoplasms, Glandular and Epithelial Drug Delivery Systems Platinum Bone Neoplasms Tumor Markers, Biological Brain Neoplasms Fallopian Tube Neoplasms

No FAQ available that match "chemotherapy paclitaxel"